MiPLA
Aliases: Lamide
Summary
MiPLA is a research chemical with very limited history of human use and minimal scientific study of its pharmacology, metabolism, and toxicity. It is approximately two to three times less potent than LSD and has a notably shorter duration of around 4-6 hours. The substance is generally described as producing less anxiety and a lighter headspace compared to LSD, with more recreational and social characteristics.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 100-150Β΅g | 150-200Β΅g | 200-250Β΅g | 300Β΅g+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 19-40 min | 45-90 min | 1-2 hrs | 1-2 hrs |
Effect Profile
7 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Psychedelic
4.9
Moderate+
5/10
Moderate headspace with mild visuals and body load
Visual Intensity
×3
5
color enhancement
pattern recognition enhancement
visual acuity enhancement
Headspace Depth
×3
6
conceptual thinking
emotion enhancement
time distortion
Auditory Effects
×1
0
Body Load / Somatic Effects
×1
4
nausea
increased heart rate
Based on reports from:
Tolerance
Build-up
develops rapidly after a single use (lysergamide)
Reset
7β14 days for baseline
Tolerance Decay
Full tolerance
1h
Half tolerance
10d
Baseline
~14d
Effects
Aggregated from 7 Erowid experience reports
Positive Effects 7
Music Enhancement
85.7%
70%
Focus Enhancement
71.4%
70%
Stimulation
71.4%
70%
Tactile Enhancement
71.4%
70%
Color Enhancement
57.1%
70%
Body High
57.1%
70%
Empathy
42.9%
70%
Adverse Effects 3
Anxiety
57.1%
70%
Memory Suppression
42.9%
70%
Nausea
42.9%
70%
Combinations
MiPLA's nerd page
Pharmacology, chemical data, effect profiles, and more
→